O vs TERN · P/E 50, rev $5.27B vs $6.12B cap
Realty Income Corporation (O) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
O currently screens at market cap $56.48B and trailing P/E 49.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the O and TERN stock pages for the full models.
Not investment advice.